← FDA Drug Approvals (Drugs@FDA)
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2023-03-21
Drug application
- FDA Application #
ANDA214688- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
- Generic name
- Betamethasone Dipropionate
- Active ingredients
- BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
- Dosage form
- AEROSOL, FOAM
- Route
- TOPICAL
- Marketing status
- Discontinued
- Sponsor
- GLENMARK PHARMS LTD
- First approval
- 2023-03-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown